Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer
Conditions
- Metastatic Skin Squamous Cell Carcinoma
- Recurrent Skin Squamous Cell Carcinoma
Interventions
- BIOLOGICAL: Cemiplimab
- RADIATION: Radiation Therapy
- PROCEDURE: Therapeutic Conventional Surgery
Sponsor
Emory University
Collaborators